文献速递消化道肿瘤放疗姑息放疗与转移瘤

RAPIDO 试验:IMRT 与 3D-CRT 治疗局部晚期直肠癌的急性和晚期放疗相关毒性比较

Acute and Late Radiation-Related Toxicity After Treatment of Locally Advanced Rectal Cancer With Intensity Modulated Radiation Therapy Compared With 3-Dimensional Conformal Radiation Therapy in the RAPIDO Trial.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2025-05-10

该研究基于 III 期 RAPIDO 试验,比较局部晚期直肠癌患者中 IMRT(含 VMAT)与 3D-CRT 的急性和晚期放疗相关毒性及治疗依从性。结果显示,IMRT 并未降低放疗相关毒性,反而在 TNT 组观察到更多急性乏力,在 CRT 组观察到更多晚期任何毒性及晚期性毒性;两组≥3 级毒性和治疗依从性无差异,持续性毒性少见。

要点

  • IMRT 未降低放疗相关毒性,部分低级别毒性反而更常见。
  • TNT 组 IMRT 后急性乏力 grade≥1 更多(OR 2.71)。
  • CRT 组 IMRT 后晚期任何毒性和晚期性毒性 grade≥1 更多。

核心结论

  • 在 RAPIDO 试验中,与 3D-CRT 相比,IMRT 未减少放疗相关毒性,部分低级别毒性在 IMRT 后更常见。

研究设计与样本

  • III 期 RAPIDO 试验的事后分析,纳入局部晚期直肠癌患者,比较 IMRT(含 VMAT)与 3D-CRT,按 TNT 组和 CRT 组分层分析急性和晚期毒性。
  • 急性毒性分析中 TNT 组 460 例、CRT 组 441 例;晚期毒性分析中 TNT 组 352 例、CRT 组 321 例;29% 患者接受 IMRT。

主要发现

  • TNT 组 IMRT 后急性乏力 grade≥1 更多(OR 2.71;95%CI 1.60-4.60;P<.001),急性恶心/呕吐 grade≥1 更多(OR 1.79;95%CI 1.15-2.79;P=.010)。
  • CRT 组 IMRT 后任何晚期放疗相关毒性 grade≥1 更多(OR 2.14;95%CI 1.28-3.57;P=.004),晚期性毒性 grade≥1 更多(OR 2.31;95%CI 1.24-4.29;P=.008)。
  • 其他 grade≥1 毒性终点、grade≥3 毒性及治疗依从性未见差异;两组持续性毒性均少见。

关键数值与推荐

  • 毒性终点按 CTCAEv4 分级,以二分类结局分析:grade≥1 vs grade 0,grade≥3 vs grade 0-2,采用单因素和多因素 logistic 回归。

临床怎么用

  • 在局部晚期直肠癌的短程放疗后巩固治疗或放化疗中,选择 IMRT 时不应预期其降低放疗相关毒性。
  • 应关注 IMRT 后急性乏力、恶心/呕吐及晚期性毒性等低级别毒性的监测与管理。

局限性

  • IMRT 仅占 29%,非随机比较,可能存在选择偏倚。
  • 部分毒性分析样本量少于总纳入人群,且持续性毒性少见限制其评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Intensity modulated radiation therapy (IMRT) aims to lower radiation-related toxicity by delivering more conformal radiation therapy compared with 3-dimensional conformal radiation therapy (3D-CRT). This study investigated whether IMRT (including volumetric modulated arc therapy) resulted in less acute and late radiation-related toxicity and better treatment compliance compared with 3D-CRT in the phase 3 RAPIDO trial. METHODS AND MATERIALS: Patients with locally advanced rectal cancer (LARC), treated with short-course radiation therapy followed by consolidation therapy (total neoadjuvant treatment [TNT] arm) or chemoradiation therapy with optional postoperative chemotherapy (CRT arm) were included. IMRT was compared with 3D-CRT, stratified by treatment arm. Acute, late, and persistent toxicity endpoints included radiation-related gastrointestinal, general, genitourinary, hematologic, and sexual adverse events (CTCAEv4). Toxicity endpoints were analyzed as binary outcomes (grade ≥ 1 vs grade 0 and grade ≥ 3 vs grade 0-2) with univariable and multivariable logistic regression analyses. RESULTS: For acute and late toxicity analyses, 460 and 352 patients were eligible in the TNT arm, respectively, and 441 and 321 patients in the CRT arm. IMRT was delivered in 29% of the patients. After IMRT in the TNT arm, more acute fatigue grade ≥ 1 (OR, 2.71; 95% CI, 1.60-4.60; P < .001) and more acute nausea/vomiting grade ≥1 (OR, 1.79; 95% CI, 1.15-2.79; P = .010) was observed compared with 3D-CRT. After IMRT in the CRT arm, more any late radiation-related toxicity grade ≥ 1 (OR, 2.14; 95% CI, 1.28-3.57; P = .004) and more late sexual toxicity grade ≥ 1 (OR, 2.31; 95% CI, 1.24-4.29; P = .008) was observed compared with 3D-CRT. No differences were found for other grade ≥ 1 toxicity endpoints, grade ≥ 3 toxicity, or treatment compliance. Persistent toxicity was rare in both groups. CONCLUSIONS: IMRT was not associated with less radiation-related toxicity compared with 3D-CRT after TNT or CRT. In contrast, some lower grade toxicities were more frequent after IMRT, in particular fatigue during TNT. Late persistent toxicity was uncommon in both groups.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Tanaka MD, Glimelius B, Hospers GAP, et al. Acute and Late Radiation-Related Toxicity After Treatment of Locally Advanced Rectal Cancer With Intensity Modulated Radiation Therapy Compared With 3-Dimensional Conformal Radiation Therapy in the RAPIDO Trial. Int J Radiat Oncol Biol Phys. 2025. PMID: 40354950. doi:10.1016/j.ijrobp.2025.04.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。